The role of hypoxia-inducible factor-1  and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes

The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia

(2012) Anna B Roehl et al.   BMC Neurology

Nitric oxide has no obligatory role in isoflurane late preconditioning against myocardial stunning

(2012) Song-Jung Kim et al.   LIFE SCIENCES

The effects of metoprolol on hypoxia- and isoflurane-induced cardiac late-phase preconditioning

(2011) A. GOETZENICH et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial KATP channel and potential pERK 1/2 activation

(2011) Paul F. Soeding et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Role of iNOS and peroxynitrite–matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats

(2010) Péter Bencsik et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The Second Window of Preconditioning (SWOP) Where Are We Now?

(2010) Derek J. Hausenloy et al.   CARDIOVASCULAR DRUGS AND THERAPY

Development of a Drug Screening Platform Based on Engineered Heart Tissue

(2010) Arne Hansen et al.   CIRCULATION RESEARCH

Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning

(2009) Stefanie Hieber et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Xenon Preconditioning Protects against Renal Ischemic-Reperfusion Injury via HIF-1  Activation

(2009) D. Ma et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A role for the RISK pathway and KATPchannels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart

(2008) E F du Toit et al.   BRITISH JOURNAL OF PHARMACOLOGY

Remote Ischemic Preconditioning: A Novel Protective Method From Ischemia Reperfusion Injury—A Review

(2008) Niteen Tapuria et al.   JOURNAL OF SURGICAL RESEARCH